Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: Marked differences between various antipsychotic drugs
2006

Differences in Antipsychotic Drug Effects on Lipogenesis in Brain Cells

publication Evidence: moderate

Author Information

Author(s): Fernø Johan, Skrede Silje, Vik-Mo Audun O, Håvik Bjarte, Steen Vidar M

Primary Institution: Department of Clinical Medicine, University of Bergen, Norway

Hypothesis

Different antipsychotic drugs have varying effects on the activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines.

Conclusion

Different antipsychotic drugs induce varying levels of SREBP-controlled transcriptional activation of lipogenesis in cultured human CNS-relevant cells.

Supporting Evidence

  • Clozapine and chlorpromazine were the most potent stimulators of SREBP target genes.
  • Glial-like cells showed more pronounced drug-induced SREBP activation compared to neuronal cells.
  • The study suggests a novel glia-mediated mechanism of action for some antipsychotic drugs.

Takeaway

Some medicines for mental health can change how brain cells make fat and cholesterol, but different medicines do this in different ways.

Methodology

The study compared the effects of six antipsychotic drugs on SREBP activation and gene expression in four human CNS-relevant cell lines.

Limitations

The clinical relevance of the findings in cell cultures may not directly translate to in vivo conditions.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2202-7-69

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication